provement in symptoms was similarly marked. The sweating, skin flush and nervousness disappeared and diarrhea, if present, stopped. Two of the cases were fibrillating before treatment was given.
One, whose fibrillation was intermittent, became consistently regular; the second, after the pulse-rate had been reduced by thiouracil, was brought back to normal rhythm with quinidine and remained normal. The effect on the eye signs and goitre was less marked. Lid retraction always decreased but exophthalmos was not noticeably altered. In the majority of cases the goitre was unaffected and, in those in which it did decrease, the decrease appeared attributable to diminished vascularity rather than to reduction of glandular tissue. It seems, therefore. that thiouracil and thiourea influence only those symptoms of thyrotoxicosis referable to overfunction of the thyroid gland, affecting slightly, if at all, those symptoms, such as the goitre itself and exophthalmos, which are believed to arise from causes outside the gland.
Thiouracil acts neither immediately nor uniformly upon the symptoms arid signs of thyrotoxicosis. The delay before its action varies in different patients. Usually little change is seen in the first and second weeks of treatment, but by the third it is evident +9o .o,j .S and by the fourth established ( fig. 2 ). In some patients, however, a good response occurs within a few days ( fig. 2) ; in others the response is slow and takes six, eight or more weeks to become established. This latter delayed reaction occurs particularly in patients who, immediately before, have been treated with iodine ( fig. 2) , and in such cases it is advisable to withhold iodine for one or two months before beginning treatment with thiouracil.
When the treatment begins to take effect the individual svmptoms are not all affected proportionately and at the same tirne. Usually the skin flush disappears early and the raised pulse-rate persists longest. Sweating, nervousness, raised metabolic rate, emaciation and-low plasma cholesterol begin to yield at intermediate times, and, generally speaking, in that order. Failure to recognize this sequence in effects has led to certain slow-reacting cases being classified as thiouracil-resistant. Three such cases have been referred to me. In each the subjective improvement, falling basal metabolic rate, and rising weight curve showed that the thyrotoxicosis was being brought under control. The contrary impression was derived from the continued elevation of the pulse-rate; and, with further treatment, this returned slowly to normal levels. 
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There thus appears to be no question that by means of thiouracil, or thiourea, thyrotoxicosis can rapidly and effectively be brought under control, and that the results of the initial treatment with these drugs are comparable to those achieved by surgery. USUAL . iMaintenance Treatment It was early realized (Astwood, 1943) that, after the initial course, thiouracil treatment must be maintained at least for some time. But it became evident that far smaller doses were required for maintenance treatment than to establish control, and that it was important to allow for this if symptoms of overdosage were to be avoided. Tbis decrease in requirements is most striking in the early stages; but it extends beyond a simple initial readjustment of dosage and there are indications that it may be progressive. Figs. 3 and 4 -illustrate this point. Fig. 3 shows that smaller and smaller (loses are required to hold the basal metabolic rate at normal levels and yet the increase in weight is maintained. Fig. 4 shows that doses of thiouracil which at first simply suffice to hold the plasma cholesterol at normal levels later prove too much so that the plasma cholesterol rises suddenly and symptoms of overdosage appear. On the basis of such observations we have been reducing the maintenance dosage more and more rapidly. Most of our patients are now taking 0 1 g. or 0-05 g. daily and in no case has a return of symptoms or a fall in weight suggested that the reduction has been too rapid or t6o much. This consideration is of particular importance in view of the dangers due to overdosage with the drug.
It would appear that a mechanism exists in the body which resists attempts to force the metabolism below normal. If this were not so then treatment should always produce a steady decrease of metabolism. This does not usually occur in man. As the basal metabolic rate approaches normal its fall slows, even though the dose of thiouracil remains unchanged. Having reached normal, there it tends to remain and its persistence at this level despite subsequent lightening of dosage, suggests that further depression of metabolism is being resisted. The practical importance of this consideration is that evidence of subnormal metabolism should not be awaited before reducing the dose of thiouracil. The dose should be decreased rapidly and continuouslv until there is THIOUREA THIOURACI L evidence that it is insufficient. Then the dose is adjusted appropriately and retained at that level for a few weeks when a further attempt at reduction is made.
The success of any therapeutic method must ultimately be judged by the efficiency with which it restores the patient to normal. In this respect, for periods up to ten months, thiouracil compares favourably with other methods of treating thyrotoxicosis. The majority of patients feel fit to resume full work in one to three months after completion of the initial treatment and, having started, are able to continue. The severity and responsibility of the work offer no bar. One patient is doing full duty as a London bus driver, another occupying a responsible managerial position, many are looking after their families unaided, and several have returned to industrial work. The disabling symptoms of Graves' disease are thus effectively controlled; but there are two signs which do not appear to be altered significantly even by prolonged treatment. These are exophthalmos and goitre. In two cases, not in my own series, the goitre had eventually to be removed because of pressure symptoms. It is as yet too early to forma an opinion whether treatmenit with thiouracil can ultimately be discontinued and the patient remain well. Undoubtedly omission of treatment in the carly stages is followed by a return of symptoms, but there are hints that later such may not be the result. One of mv patients after treatment with thiourea for seventy days, discontinued the drug and has had no treatment for five months. There has been no return of symptoms and she has maintained her weight. Two others have been off treatment with thiouracil for five and seven weeks respectively without showing any untoward effects. None of these cases was severe and before omission of treatment all had been weaned on to very small doses of the drug. It remains to be seen whether their present freedom from thyrotoxic symptoms will be maintained and whether or not this favourable result is unusual.
Overdo.sage If thio'iracil and thiourea had no untoward effects it would now be reasonably certain that an efficient medical treatment of thyrotoxicosis had been devised. Unfortunately they have such effects and only experience can show whether these occur so frequently as to render treatment with these drugs more dangerous than surgical removal of the gland. In considering their ill-effects it is important to distinguish the effects due to overdosage from those due to idiosyncrasv. By the manifestations of overdosage are meant those symptoms which can be induced in any patient by excessive doses of the drug. By the manifestations of idiosyncrasy are meant those conditions which occur capriciously and inconstantly in a minority of patients.
The manifestations of overdosage can be divided into two groups: The first, which is easily recognized and avoided, occurs early in treatment and from gross overdosage. The second develops insidiously and then quickly becomes manifest, and apparentlv results from chronic, slight overdosage. Gross overciosage shows itself by an increase in size, sometimes painful, of the goitre. Our first case was discharged from hospital on 2 g. of thiourea daily. He then wore a 15%4 in. collar. Within the next two months his neck increased in size so that a 17 in. collar was too small. On reducing the dose to 05 g. daily the neck slowly decreased to its original size. A second mild case, who had previously undergone a subtotal thyroidectomy, developed painful nodules all along the operation scar. A third case with a retrosternal goitre developed pressure symptoms. Since adopting a more rapid reduiction of dosage after the initial course of treatment few cases of this kind have been seen, and on further reductioni of the dose these have all been rapidly relieved.
Chronic, slight overdosage shows itself mainly by subjective svmptoms. A patient who for weeks or months has been on the same small dose of thiouracil, and who has previously continued to remark on her improved well-being, comes up complaining of weariness and depression. Not infrequently such cases have a bloated appearance and their friends remark on their lack of energy. Superficially the evidence suggests hypothyroidism but inspection of the weight chart usually shows that the weight has been constant for weeks and determination of the basal metabolic rate shows no depression. This state is associated with, and often preceded by, an elevation of the plasma cholesterol ( fig. 4 ). On reducing the dose the symptoms rapidly disappear and the plasma cholesterol falls. In passing it should be noted that these symptoms are not associated with alteration in the white blood cell count. There is insufficient evidence available at present to decide on the pathogenesis of thlese svmptoms. Are they indeed the first signs of rapidly developing hypothyroidism or are they the results of a toxic action of the drug? The former explanation appears the more probable. But whatever the explanation this type of overdosage is particularly prone to develop during maintenance treatment and can be avoided by reducing the dose to the minimum required to maintain the weight. As a further check the blood cholesterol level can be determined periodically and, if this is rising unduly, the dose of thiouracil should be reduced.
Idiosyncrasy
Fever, rashes, enlargement of lymph glands and blood changes have been reported as manifestations of sensitivity to thiouracil (Astwood, 1943; Cabrilove and Kert, 1944; Newcombe and Deane, 1944) . Fever occurred in 3 of the 33 cases. In 2 it could be accounted for by a coincident infection, one patient having a streptococcal infection of the throat, the other an active infection by B. coli of the urinary tract. In both cases the temperature subsided with the infection and did not rise when thiouracil was again given. In the third case no infective cause was found. The fever occuirred after the patient had been taking I g. of thiouracil daily for eight days and as, unlike the other two, it was associated with a neutropenia the drug was discontinued.' The temperature then fell. One patient showed a maculopapular rash on the fifteenth day of therapy with 1 g. of thiouracil daily. As it was unassociated with either fever or leucopenia the drug was continued, though at the reduced dose of 0-4 -g. daily; and the rash faded during the next three days. Enlargement of lymph glands has not beeni observed in our series.
These three manifestations of sensitivity resemble those occuirring after many other drugs, not only in their nature but in the delay before their appearance. All have'been reported as occurring within a fortnight or so of exposure to the drug and they have not been observed after this time even in cases which have been under treatment "for many months. Their appearance early in treatment may be due to the heavy doses'of the drug used in the first fortnight, but that this is not the most important factor in their production is evident from the fact that the majority of patients take such doses with impunity. A special sensitivity to the drug is presumably present in the persons affected. In that case the failure of these particular ill-effects to appear after the first fortnight suggests either that the sensitive subjects are few in nuinber and eliminated by early detection, or that desensitization is effected by contintled treatment.
The most serious manifestations of sensitivity are those which affect the formed elements of the blood. Leucopenia, agranulocytosis (Astwood, 1943) and thrombocytopenia (Newcombe and Deane, 1944) have been reported. The latter has not occurred in our series but there have been two cases of leucopenia and one case of agranulocytosis out of the 33 cases. The first case of leucopenia was the above patient with the unexplained temperature. At the beginning of the febrile attack the white blood cell count had fallen fromt 7,800 with 84% of neutrophils to 2,000. At the height of the fever it was 4,400 wit;h 35% neutrophils. The second case received 1 g. of thiouracil daily for fourteen days when a routine blood-count showed 1,100 white cells withl 50% neutrophils.
Treatment was discontinued and the blood-count rose. This patient had no untoward symptoms throughout. The third case had, on admission, a white count of 10,000 with 68% neutrophils. After treatment for one month with 1 g. of thiouracil daily no improvement in the thyrotoxicosis had occurred. This was attributed to her having received iodine daily for two years before admission. As there had been no toxic symptoms and the white cell count was 9,300 the dose of thiouracil was raised to 2 g. daily. At the end of a further fortnight the thyrotoxicosis had responded, the white cell count was 6,000 with 60% of neutrophils, and the patient was discharged on 0-6 g. daily. Eight days after discharge she developed a whitlow, two days later she felt chilled, the temperature rose to 104°F. and two days after she developed a sore throat. On admission she had 1,500 white cells with no neutrophils and only a few primitive cells were present in the steriial marrow. Vigorouis treatment with fresh blood transfusions and pentnucleotide was given. Neutrophils returned to the blood four davs later. Six days after admission the white count was 26,000 with 76% of neutrophils and the sternal marrow showed vigorous activity and niature cells. Then, unfortunately. she contracted a bronchopneumonia and from this she died.
Agranulocytosis being the most dangerous complication of treatment with thiouracil or thiourea it is important to consider the factors concerned in its production. It is evident that idiosyncrasy plays a part. If an invariable action of these drugs were to depress the production of neutrophils then it would be expected that these would fall in all patients. This does not happen. In the series of 22 patients shown in the table the' white cell counts on admission ranged from 4,000 to 10,000 -with an average of 6,513; the neutrophils ranged from 42% to 80% with an average of 59 3%. Oni the completion of the initial treatment the whitecounts ranged from 3,000 to 11,600 and averaged 6,865; the neutrophils ranged from 40% to 81 % and averaged 59-6%. Throughout the period of maintenance treatment white cell counts have been done on all patients at intervals of not more than one month. Again there is no evidence of a consistent and steady depression of neutrophils as treatment continues. Neutropenia, whei it occurs, appears suddenly in patients whose previouis blood-counts have been normal both in respect of total white eells and total neutrophils. There is a hint, ho;wever, that its superv'ention may be foreshado-wed by the appearance of many young n'eutrophi1s in the peripheral blood. This possibility is being investigated. Lastly, neutropenia does not develop until a week or more after treatmen-t has commenced, an observation which mav be explained either by a cumulative toxic effect or a developing sensitivity. Despite this cvidence of idiosvncrasy, there is, hovever, an indication that the development of neutropenia is also influenced by the dose of thiouracil used; not by the total dose given over many months but by the intensity of the daily dosage. The three cases reported here all occurred either during or shortlv after inten.sive treatment. Astwood's fatal case was receiving 2 g. of thiouracil daily; Newcombe and Deane's case of thrombocytopenia and leucopenia had taken 83 g. of thiourea in five weeks; and a third fatal case, of which I have been informed, had received 103 g. of thiourea an(d 62 g. of thiouracil in five months. As far as I am aware no cases have been reported of any manifestations of sensitivity in patients taking thiouracil in small doses of the order of 0-1 or 0-05 g. a day.
It thus appears that two factors are involved in the production of this untoward effect of thiouLracil: idiosyncrasy and dosage. If this be so then we mav hope to avoid it by uising small doses of the drug. For this reason, and because of the evidence that the maintenance doses have been greater than necessary, it seems advisable to use, in all stages of the treatment, smaller doses of thiouracil than have been used up to now. The dosage which is being tested at present is 0-5 g. dailv until the B.M.R. falls to about + 10'S/,. Thereafter the dose is decreased to 0 1 g. or 0-05 g. daily during the maintenance period.
It is hoped, on the basis of analogy with the sulphonaniide drugs, that by using these smaller doses and reducing the dose more rapidly a safe yet effective technique of this promising therapy may be evolved. For the present, however it, should be realized that thiouracil therapy is still in the experimental stage and that it should only be used under circuLmstances which allow close, detailed and continued investigation of the patients.
Mr. C. A. Joll (in absentia): There have been so many calls from practitioners and others to be supplied with thiouracil and thiourea for the trcatment of their patients that it seems desirable to give a preliminary report of the results we have been getting, both good and bad, if only to make it clear to those who wish to make use of these powerful and dangerous drugs that some of the optimistic statements which have been made in this country-be it emphasized, often on a very slender experience-are at any rate extremely ill-judged.
Thyrotoxicosis is a name which embraces a group of diseases, among which the form which we call primary thyrotoxicosis or Graves' disease is perhaps best understood. It is also the easiest form to diagnose and, in some ways, to treat, and it is associated with a hyperplastic thyroid gland which, in spite of infinite variations in detailed histology, conforms more or less closely to tvpe. I was glad to note that this Section has used the term "thyrotoxicosis" and not begged the question of the nature of the disease by using the unjustifiable term hyperthyroidismn, since we do not even know the exact nature of the normal thyroid hormone, much less the chemistry of the abnormal products associated with thyrotoxicosis. So far, all or nearly all the work on thiouracil and thiourea has been in connexion with this variety of thyrotoxicosis and little or nothing lhas emerged in relation to the much larger, more insidious and more hazardous groups of cases we include under "secondary thyrotoxicosis". The pathology of this "secondary" type is the reverse of uniform and in fact thyrotoxic symptoms may be met with in nearly every variety of pathological thyroid gland, but on the whole one may say that in this vast and inchoate group hyperplastic changes are either entirelv absent or at any rate inconspicuous in degree or trivial in extent. It is hardly to he expected that the hvperinvoluted thyroid gland met with so often in these circumstances is as likely to respond to substances such as thiouracil and thiourea by increased hyperplasia as do the forms in which diffuse hyperplasia already exists. It is probably wise until our information is more complete in connexion with the relatively simpler problem of primary thyrotoxicosis, not to conifuse the issue by exhibiting thiouracil in the secondarv forms of thyrotoxicosis.
Wartime conditions have limited the number of cases we have been able to observe to between 20 and 30, and of these I have takeii only 9 cases which are fully documented to illustrate our results. Group 1: 6 cases showing favourable results. Group II: 3 cases showing unfavourable results.
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Group 1.-Favourable cases: In this group 3 cases should be regarde(d as very mild in degree, one of moderate severity and two severe. CASE I.-K. S., female, aged 42. A classical severe case with a ten-months' history of nervousness, trembling and palpitations. Loss of weight 2 st. in ten months. The B.M.R. was + 49% and the heart overacting. Thiouracil 0.6 g. daily for twenty days was given followed by a maintenance dose of 0-2 g. as an out-patient for five weeks. In fifty days she had put on 1 st. in weight and felt better, although her B.M.R. did not fall and her pulse-rate remained about 100. .=. She has failed to go on with her maintenance dose of thiouracil and her condition has deteriorated rapidly although there is a slight gain in weight. Her heart is severely overactive and her pulse-rate has risen to 150. She refuses operation-and a significant fall in polymorphonuclear leucocytes over four months after cessation of the drug makes future treatment difficult. CASE II.-B. L., female, aged 52. A case of moderate severity with four years' history of fatigue, tremor and palpitations. A small hyperplastic goitre was palpable. She had obvious exophthalmia. Her B.M.R. was + 46%. Thiouracil 0-6 g. daily for three weeks was given followed by 0-2 g. daily maintained as an out-patient. In ten weeks in-patient treatment. As an *out-patient the B.M.R. rose to normal, the pulse to 90, but she continued to feel well and to put on weight. CASE IV.-J, T., female, aged 19. A mild case with a history of palpitations of only three months' duration. There had been no loss of weight. The pulse-rate was abnormally high (140) but the B.M.R. only +21%. Thiouracil 0-6 g. daily for three weeks was given, then 0.2 g. daily as an out-patient. Over a period of six months she has put on 1 st. in weight and her '3.M.R. has fallen to -29%. The effect on the pulse has never been quite as marked, it is still 100-a disadvantage, since this was her presenting symptom. She developed purpura under treatment and the drug has therefore been stopped temporarily. Previous treatment had included two courses of deep X-ray therapy at another hospital, in addition to iodine therapy and psychological treatment. The B.M.R. rose from +16% to +44% during treatment and on admission to us the B.M.R. was estimated at +125%. Thiouracil 1-2 g. daily for one week was given, then 0.6 g. daily for one week followed by 0.2 g. daily for two weeks maintained as an out-patient. His clinical condition improved in every respect during in-patient treatment, the pulse fell from 102 to 75, he put on 12 lb. in weight and the B.M.R. fell to -20%. After five months on the maintenance dose of 0-2 g. his pulse is 60, his weight has gone up a further 24 lb. and the B.M.R. is -24%. There has been a slight tendency to a fall in his white blood-count but this is not apparently progressive. CASE VI.-D. S., female, aged 38. A mild case, with five weeks' history of nervousness, palpitations and sweating. There was no exophthalmos. The pulse was 130 and the B.M.R. +32%. A typical hyperplastic goitre was palpable. Thiouracil 1-2 g. daily for one week was given, then 0.6 g. daily for one week followed by 0.2 g. daily for one week.
There was a definite improvement in all the physical signs including a fall in pulse-rate and in B.M.R. to -12%. The patient said, however, that she felt no better and requested operation, which was carried out. Sixteen weeks later her B.M.R. is -40% and her weight has risen from 7 st. 81 lb. to 8 st. 10 lb. (This is a case which should not be regarded as a thiouracil failure, but rather one in which its effect was purelyphysical, while the patient's symptoms were markedly psychical.) Group II.-Unfavourable cases. CASE VII.-D. R., female, aged 41. A moderately severe case with a history of loss of 3 st. in weight, palpitations and dyspncea for a year and a half. She had had iodine therapy ni xx t.d.s. for only two weeks before admission.
Her B.M.R. was +65%. Thiouracil 1.2 g. daily for seven days was given, then 0-6 g. daily for seven days, followed by 0-2 g. daily for six days.
Under this regime the B.M.R. fell slightly to +54%, but her weight fell' a further 5 lb. and the pulse was unaffected. The patient chose operative treatment rather than the risk of further deterioration. After operation the B.M.R. fell to + 6%, her weight rose and pulse fell rapidly. CASE VIII.-E. B., female, aged 39. A severe case with a history of at least two years' duration, with loss of weight, palpitations and nervousness. She had had prolonged iodine therapy elsewhere. Her pulse was 130 and her B.M.R. +67%. Thiouracil 0.6 g. daily for one week was given followed by 0-4 g. daily for two weeks.
There was very little fall in pulse-rate or B.M.R. and the patient asked for operation, since she felt no better. Eighteen days after the operation the B.M.R. had fallen to -4%, the pulse to 70 and weight had begun to rise. CASE IX.-L. S., female, aged 36. A moderate case with a classical history of fatigue, palpitations, loss of weight. &c. She had had four months' iodine therapy. The B.M.R. was +43c^and the heart severely overacting. Thiouracil 0-6 g. daily was given. After three weeks there was a sudden fall in blood granulocytes (absolute polymorp4. count of 31) with ulceration of fauces and pyrexia to 102°F. No improvement in the bloodcount followed discontinuance of thiouracil until six days later, when gradual improvement was noted after a fresh blood transfusion. The B.M.R. rose to +53% six weeks after starting treatment, the pulse-rate was not improved and a further fall of bodyweight was noted.
Thyroidectomy two months after admission resulted in a fall of B.M.R. to -19% and of pulse-rate to 80.
To sum up this brief series, it would be fair to include Case VI in the number which I have stated to be so far favourable, since no adverse thiotiracil effect was noticed and the patient's lack of co-operation was the main obstacle to success.
If this be conceded, then two-thirds of the cases responded well to thiouracil and onethird unfavourably. This is, however, very far from claiming that similar figures could be obtained over a really large series and it leaves quite untouched the great mass of thyrotoxic cases which are not in t-he "primary" category. I very much hope that this line of treatment will be followed up under strict control and that the manufacturing chemists will not release these powerful and dangerous drugs to all and sundry. Much work still remains to be carried out, I submit, in connexion with the 'value of thiouracil, not necessarily as a method of treatment stui getneris but in relation to the possibility of using it instead of i-odine therapy as a means of preparation for operation. If the optimum reduction in thyrotoxicosis could be rapidly obtained (as seems possible) so that operative risks could be ignored, then an epoch-making step will have been made in the therapeusis of thyrotoxicosis.
Dr. Horace Evans: I have had the opportunity of treating twelve thyrotoxic patients N ith thiouracil, eight of these under careful control at the London Hospital. In every instance the result was very satisfactory, closely agreeing with Himsworth's cases. The exophthalmos, with one exception, was not improved. No ill-effects of the drug occurred, but in one patient a transient neutropenia was observed. In a critical review of these cases it must be remembered that even in the best hands the results of surgical treatment are by n.o means always good. It is of course too early to ju!dge final results of thiouracil therapy but I feel that the initial treatment is satisfactory. This treatment is still in the experimental stage and the use of this drug, except under careful control, is to be deprecated.
Dr. G. Melton: The following case illustrates the influence of thiouracil on auricular fibrillation complicating thyrotoxicosis. B.M.R. continued to fall, weight to increase and other thyrotoxic signs and symptoms cleared up, apart from the goitre and exophthalmos. Since discontinuing thiouracil her condition has remained satisfactory for six months. She also has essential hypertension, which was a probable factor in the production of her congestive failure, particularly in view of the striking improvement which followed rest and digitalization.
Dr. S. L. Simpson said that although the interpretations of the data presented by Professor Himsworth and Mr. Joll apparently differed in some respects, there was a large measure of agreement in the objective data presented. There was no doubt that, in a good proportion of patients with thyrotoxicosis, thiouracil produced a significant and often dramatic fall in pulse-rate and basal metabolic rate, and an increase in weight. The increase in weight was sometimes disproportionately great and might be due, in addition to the decreased metabolic rate, to the changes produced in the pituitary gland, namely, hypertrophv, hyperplasia, and vacuolization of the basophil cells. Further investigation would determine which types of thyrotoxicosis were refractory to thiouracil, but there did not appear to be sufficient evidence in support of the statement that secondary thyrotoxicosis (toxic adenoma) was refractory. That thiouracil did not abolish exophthalmos was not surprising, since thyroidectomv often failed to influence exophthalmos, a condition wvhich could be produced by the pituitary thvrotrophic hormone in the absence of the thyroid gland. Both thiouracil and thyroidectomy, however, diminished, or abolished, pathological lid retraction, and the associated characteristic staring expression of thyrotoxic patients.
Thiouracil acted by inhibiting the synthesis of thyroxine, to which the organism responded by an increased secretion of the pituitary thyrotrophic hornlone, and resulting increased hvperplasia of the thyroid gland. It therefore was only to be expected that the thyroid gland would not diminish in size and might increase in size. Therefore, thiouracil should not be used in patients where pressure symptoms were already a feature, or where a grossly enlarged thyroid gland was unacceptable for aesthetic or psychological Proceedings of the Royal Society of Medictne 36 reasons. The tadpole was the onlv experimental animal where thiouracil produced an atrophy of the thyroid rather than a hyperplasia. It might be that hyperplasia in man would, after some time, give way to exhaustion atrophy, p)erhaps with mvxoedema, as sometimes happened spontaneously.
Both thiouracil and thiourea were dangerous drugs, and in addition to the reactions recorded by others, Dr. Simpson stated that in one of his patients in whom thiourea produced a fall in basal metabolic rate from +46', to -203X, delusional insanity developed. This might occur spontaneously in both thvrotoxicosis and myvcedema, bult its onset within a few weeks of starting the drug could not be ignored. Nevertheless, thiouracil, or a modified substance, without its toxic reactions, would probably find an important place in medical therapeutics. At present it shoUld only be Llsed with caution and under controlled conditions. Professor Himsworth, in replv, said that in his experience thiouracil had worked effectively in all types of thyrotoxicosis. The three cases reported by Mr. Joll in which its action had been slight or absent could adequately be accounted for by the fact that all three had received iodine up to the time of commencing thiouracil treatment and that after such premedication little effect from thiouracil would be seen in the short periods of treatment of three and four weeks which these cases received.
